<DOC>
	<DOCNO>NCT03083769</DOCNO>
	<brief_summary>The purpose study determine whether functional genetic variant affect tacrolimus dose correct trough level associate side effect Chinese renal transplantation liver transplantation .</brief_summary>
	<brief_title>Functional Genetic Variants Affecting Tacrolimus Trough Levels Side Effects Chinese Renal Transplantation Liver Transplantation .</brief_title>
	<detailed_description>Tacrolimus effective immunosuppressive drug widely use solid organ transplantation prevent rejection . It characterize narrow therapeutic range large inter- intra- individual variability pharmacokinetics . Many factor associate variability . Of factor , genetic factor play important role . Full understand mechanism important personalize use tacrolimus reduce risk side effects.The CYP3A5*3 ( A6986G ) result splice defect absence protein activity , identify functional variant ( Kuehl P.2001 ) . The CYP3A4*1G also report functional variant ( Richards-Waugh LL . 2014 ) . In addition , functional variant also identify analyzed project . Our project two part : first , retrospective study , 1000 renal patient two center ( two cohort , one center ) use tacrolimus immunosuppressive drug recruit . In two cohort , functional genetic variant affect dose correct tacrolimus trough level identify . Second , prospective study , part , two cohort , renal transplantation cohort liver transplantation cohort . For renal transplantation cohort , patient stratify different group accord different genotype . The side effect ( acute rejection , nephrotoxicity neurotoxicity ) observe . For liver transplantation cohort , patient stratify different group accord different donor ' genotype side effect ( acute rejection , nephrotoxicity neurotoxicity ) also observe . During study period , therapeutic procedure patient usual . This large cohort kind study Chinese population . The finding useful patient improve therapeutic efficacy reduce side effect .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Subject conduct liver kidney transplantation . Subject use tacrolimus immunosuppressant History longterm hormone therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>genetic variant</keyword>
	<keyword>side effect</keyword>
</DOC>